Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- Corcept Therapeutics Inc
Updated Jul 16, 2026
Cannon Gillian has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $63K.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-09 | XENE | Xenon Pharmaceuticals Inc. | S — Open-market sale | 1.2K | $53.14 | $63K |
| 2026-06-04 | XENE | Xenon Pharmaceuticals Inc. | M — Option exercise | 2.6K | — | |
| 2025-09-10 | CORT | CORCEPT THERAPEUTICS INC | G — Bona-fide gift | 7.4K | $0.00 | |
| 2025-09-04 | CORT | CORCEPT THERAPEUTICS INC | F — Tax withholding / forfeiture | 3.6K | $70.13 | $253K |
| 2025-09-04 | CORT | CORCEPT THERAPEUTICS INC | M — Option exercise | 11.0K | $22.99 | $253K |
Cannon Gillian is a corporate insider — currently tracked as Insider of Xenon Pharmaceuticals Inc. (XENE). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($63K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cannon Gillian profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.